Back to Agenda
Medable Innovation Theater: Enabling Decentralized Clinical Trial Readiness for your Organization
Session Chair(s)
Medable
United States
The time for rapid change within clinical trials is now. Medable recognizes the shifts taking place and the adaptations required in the clinical industry in order to harness and optimize the benefits and value opportunities. Join Medable for a discussion on DCT adaptation from a scientific, operational, and innovative technology perspective, transforming drug development into a new era of digitally enabled, decentralized solutions making research access ubiquitous to all.
Speaker(s)
Rasmus Hogreffe, MBA, MSc
Rasmus Hogreffe, MBA, MSc
Medable, Denmark
Vice President, Decentralized Clinical Trial Innovation
Pamela Tenaerts, MD, MBA
Pamela Tenaerts, MD, MBA
Medable, United States
Chief Scientific Officer
Andrew Mackinnon
Andrew Mackinnon
Medable, United States
Digital and Decentralized Trial Solutions Operational Strategy Lead
Have an account?